TY  - GEN
AU  - Suttle,A Benjamin
AU  - Grossmann,Kenneth F
AU  - Ouellet,Daniele
AU  - Richards-Peterson,Lauren E
AU  - Aktan,Gursel
AU  - Gordon,Michael S
AU  - LoRusso,Patricia M
AU  - Infante,Jeffrey R
AU  - Sharma,Sunil
AU  - Kendra,Kari
AU  - Patel,Manish
AU  - Pant,Shubham
AU  - Arkenau,Hendrik-Tobias
AU  - Middleton,Mark R
AU  - Blackman,Samuel C
AU  - Botbyl,Jeff
AU  - Carson,Stanley W
TI  - Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib
SN  - 1552-4604
PY  - 2016///0314
KW  - Anticoagulants
KW  - pharmacokinetics
KW  - Cytochrome P-450 CYP2C8 Inhibitors
KW  - pharmacology
KW  - Cytochrome P-450 CYP3A Inhibitors
KW  - Drug Interactions
KW  - Female
KW  - Gemfibrozil
KW  - Humans
KW  - Imidazoles
KW  - administration & dosage
KW  - Ketoconazole
KW  - Male
KW  - Middle Aged
KW  - Oximes
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins B-raf
KW  - antagonists & inhibitors
KW  - Warfarin
N1  - Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/jcph.437
ER  -